Wenbing Yao

Title: The Innovations of Wenbing Yao

Introduction

Wenbing Yao is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative peptides and recombinant proteins. With a total of 2 patents, his work has the potential to impact vaccine development and cancer treatment.

Latest Patents

Wenbing Yao's latest patents include two groundbreaking inventions. The first patent is for a helper epitope peptide and its application. This peptide is derived from the helper T cell epitope PADRE, modified by replacing one or two amino acid residues with 4-nitrophenylalanine. This innovation enhances the immunogenicity of antigens, making it valuable for vaccine preparation. The second patent involves a modified recombinant human endostatin. This compound, characterized by its structure CHO—(CHCHO)—CHCHCH—NH-Endostar, boasts an average molecular weight of 20-40 kD. It improves stability in vivo, increases blood drug concentration, and prolongs half-life, thereby enhancing its efficacy in inhibiting endothelial cell proliferation.

Career Highlights

Wenbing Yao has worked with prominent institutions, including China Pharmaceutical University and Jiangsu Simcere Pharmaceutical R&D Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical research.

Collaborations

Wenbing Yao has collaborated with notable colleagues, including Hong Tian and Xiangdong Gao. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Wenbing Yao's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work has the potential to significantly improve vaccine development and cancer treatment, marking him as a key figure in his field.